Corient Private Wealth LP Takes Position in Agilent Technologies, Inc. $A

Corient Private Wealth LP bought a new position in shares of Agilent Technologies, Inc. (NYSE:A) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 243,555 shares of the medical research company’s stock, valued at approximately $32,352,000.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Bamco Inc. NY acquired a new position in Agilent Technologies in the 2nd quarter valued at $4,860,000. Bank of America Corp DE acquired a new stake in shares of Agilent Technologies during the second quarter worth $213,269,000. Birmingham Capital Management Co. Inc. AL purchased a new stake in shares of Agilent Technologies in the second quarter valued at $229,000. Freestone Grove Partners LP purchased a new stake in shares of Agilent Technologies in the second quarter valued at $91,081,000. Finally, Caisse de depot et placement du Quebec acquired a new position in Agilent Technologies in the second quarter valued at $1,695,000.

Analyst Upgrades and Downgrades

A number of analysts have issued reports on A shares. Morgan Stanley raised their price target on Agilent Technologies from $160.00 to $175.00 and gave the stock an “overweight” rating in a research note on Wednesday, August 12th. Royal Bank Of Canada increased their price objective on shares of Agilent Technologies from $155.00 to $185.00 and gave the stock an “outperform” rating in a report on Thursday. Robert W. Baird raised their target price on shares of Agilent Technologies from $155.00 to $156.00 and gave the stock an “outperform” rating in a research report on Tuesday, May 26th. Barclays boosted their target price on shares of Agilent Technologies from $150.00 to $175.00 and gave the company an “overweight” rating in a report on Thursday. Finally, Piper Sandler began coverage on shares of Agilent Technologies in a research report on Thursday, June 11th. They set a “neutral” rating and a $150.00 price target for the company. One analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and four have issued a Hold rating to the company. Based on data from MarketBeat, Agilent Technologies presently has a consensus rating of “Moderate Buy” and an average price target of $170.33.

Trending Headlines about Agilent Technologies

Here are the key news stories impacting Agilent Technologies this week:

• Positive Sentiment: Agilent reported fiscal Q3 revenue of $1.88 billion, up 8.1% year over year and ahead of the $1.84 billion consensus estimate. Adjusted EPS was $1.62, beating expectations of approximately $1.49 and rising from $1.37 a year earlier. Operating profit, cash flow and margins also improved. Agilent Reports Third-Quarter Fiscal Year 2026 Financial Results
• Positive Sentiment: The company raised its fiscal 2026 outlook to adjusted EPS of $6.18-$6.21, above the $6.06 analyst consensus, and projected approximately $7.5 billion in revenue versus expectations of $7.4 billion. Management cited improving demand for laboratory instruments used in research and drug development. Agilent raises annual profit forecast on improving lab tools demand
• Positive Sentiment: Analyst sentiment strengthened significantly following the results. Citigroup and JPMorgan raised their price targets to $190, while RBC lifted its target to $185. Barclays, Stifel, Goldman Sachs, Bank of America, TD Cowen and Bernstein also raised targets, with most assigning Buy, Overweight or Outperform ratings. The revised targets imply roughly 11%-21% potential upside from the referenced trading level. Analyst price-target revisions
• Neutral Sentiment: Agilent is trading near its 52-week high and above both its 50-day and 200-day moving averages. That momentum supports investor confidence, although the stock’s valuation—around 32 times earnings and a PEG ratio above 2.7—leaves less room for disappointment.
• Neutral Sentiment: Institutional positioning was mixed in the latest filings: 594 investors added shares while 550 reduced holdings. Significant purchases by FMR, JPMorgan, Bank of New York Mellon and T. Rowe Price were offset by large sales from several other institutions.

Agilent Technologies Price Performance

A opened at $157.60 on Friday. The company has a quick ratio of 1.62, a current ratio of 2.10 and a debt-to-equity ratio of 0.43. The company has a market cap of $44.51 billion, a P/E ratio of 31.02, a P/E/G ratio of 2.74 and a beta of 1.25. The company has a 50 day moving average of $139.76 and a two-hundred day moving average of $126.85. Agilent Technologies, Inc. has a 52-week low of $108.35 and a 52-week high of $163.75.

Agilent Technologies (NYSE:A) last announced its quarterly earnings results on Wednesday, August 26th. The medical research company reported $1.62 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.49 by $0.13. Agilent Technologies had a return on equity of 24.84% and a net margin of 19.53%.The firm had revenue of $1.88 billion during the quarter, compared to the consensus estimate of $1.84 billion. During the same period in the prior year, the firm earned $1.37 EPS. The firm’s quarterly revenue was up 8.1% compared to the same quarter last year. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. On average, analysts expect that Agilent Technologies, Inc. will post 6.05 earnings per share for the current year.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.